Northern Trust’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-17,058
| Closed | -$96.9K | – | 4457 |
|
|
2025
Q4 | $96.9K | Buy |
17,058
+3,752
| +28% | +$21.2K | ﹤0.01% | 4146 |
|
|
2025
Q3 | $81.4K | Sell |
13,306
-3
| -0% | -$16 | ﹤0.01% | 4181 |
|
|
2025
Q2 | $42.6K | Sell |
13,309
-23,682
| -64% | -$91.2K | ﹤0.01% | 4258 |
|
|
2025
Q1 | $150K | Sell |
36,991
-3,316
| -8% | -$23.3K | ﹤0.01% | 4023 |
|
|
2024
Q4 | $427K | Buy |
40,307
+1,125
| +3% | +$20.1K | ﹤0.01% | 3708 |
|
|
2024
Q3 | $968K | Buy |
39,182
+2,591
| +7% | +$68.5K | ﹤0.01% | 3372 |
|
|
2024
Q2 | $1.03M | Sell |
36,591
-1,738
| -5% | -$56.5K | ﹤0.01% | 3237 |
|
|
2024
Q1 | $1.56M | Buy |
38,329
+1,020
| +3% | +$24K | ﹤0.01% | 3090 |
|
|
2023
Q4 | $616K | Buy |
37,309
+223
| +0.6% | +$3.89K | ﹤0.01% | 3472 |
|
|
2023
Q3 | $1.41M | Sell |
37,086
-343
| -0.9% | -$16.2K | ﹤0.01% | 3124 |
|
|
2023
Q2 | $2.06M | Sell |
37,429
-1,080
| -3% | -$49.6K | ﹤0.01% | 2987 |
|
|
2023
Q1 | $1.66M | Sell |
38,509
-4,006
| -9% | -$194K | ﹤0.01% | 3020 |
|
|
2022
Q4 | $1.67M | Buy |
42,515
+1,145
| +3% | +$60.1K | ﹤0.01% | 3085 |
|
|
2022
Q3 | $2.2M | Buy |
41,370
+111
| +0.3% | +$6.94K | ﹤0.01% | 2970 |
|
|
2022
Q2 | $2.71M | Buy |
41,259
+841
| +2% | +$55K | ﹤0.01% | 2884 |
|
|
2022
Q1 | $2.97M | Sell |
40,418
-1,600
| -4% | -$92.7K | ﹤0.01% | 2888 |
|
|
2021
Q4 | $2.98M | Sell |
42,018
-1,534
| -4% | -$268K | ﹤0.01% | 3012 |
|
|
2021
Q3 | $10.9M | Buy |
43,552
+3,009
| +7% | +$721K | ﹤0.01% | 2204 |
|
|
2021
Q2 | $10.9M | Buy |
40,543
+1,796
| +5% | +$537K | ﹤0.01% | 2305 |
|
|
2021
Q1 | $11M | Buy |
38,747
+23,797
| +159% | +$7.62M | ﹤0.01% | 2227 |
|
|
2020
Q4 | $4.24M | Sell |
14,950
-18
| -0.1% | -$5.78K | ﹤0.01% | 2776 |
|
|
2020
Q3 | $4.63M | Buy |
+14,968
| New | +$3.58M | ﹤0.01% | 2581 |
|
Other funds holding GBIO
Northern Trust's GBIO Position: Q1 2026 in Review
Northern Trust sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 17,058 shares — an estimated $96.9K sold.
Northern Trust first reported a position in GBIO in Q3 2020 and held it in 22 quarters. The position peaked at $11M in Q1 2021. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.
- Northern Trust reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
- Northern Trust sold 17,058 Generation Bio shares in Q1 2026, an estimated $96.9K.
- Northern Trust first reported a position in Generation Bio in Q3 2020 and held it in 22 quarters.
- Northern Trust's Generation Bio position peaked at $11M in Q1 2021.
- 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.